New research in The FASEB Journal suggests that an abnormal amount of an inflammatory protein called PAR2 is present on abdominal fat tissues of overweight and obese humans and rats
Scientists have moved a step closer to an “obesity drug” that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that there is an abnormal amount of an inflammatory protein called PAR2 in the abdominal fat tissue of overweight and obese humans and rats. This protein is also increased on the surfaces of human immune cells by common fatty acids in the diet. When obese rats on a diet high in sugar and fat were given a new oral drug that binds to PAR2, the inflammation-causing properties of this protein were blocked, as were other effects of the high-fat and high-sugar diet–including obesity itself.
“This important new finding links obesity and high fat high sugar diets with changes in immune cells and inflammatory status, highlighting an emerging realization that obesity is an inflammatory disease,” said David P. Fairlie, Ph.D., study author from the Institute for Molecular Bioscience at the University of Queensland, in Bribane, Australia. “Drugs designed to block certain inflammatory proteins, as in this report, may be able to prevent and treat obesity, which in turn is a major risk factor for type 2 diabetes, heart disease, stroke, kidney failure, limb amputation, and cancers.”
To make this discovery, Fairlie and colleagues discovered the first potent, selective and orally bioavailable small molecule antagonists of PAR2 and characterized their functional responses in inflammatory cellular and animal models. They found that PAR2 expression is increased in vivo in adipose tissue from obese humans and rats, stimulated in vitro in human macrophages by the dietary fatty acid palmitic acid, and inhibited in vivo and in vitro by a PAR2 antagonist. This antagonist was then used as a tool to dissect roles for PAR2 activation in mediating metabolic dysfunction in human monocyte-derived macrophages (HMDM), human and rodent adipocytes, and diet-induced obesity in rats. Oral treatment of diet-induced obese rats attenuated PAR2 signaling in adipose tissue and inhibited adipose inflammation, insulin resistance, diet-induced obesity and cardiovascular abnormalities. This is the first report that a PAR2 antagonist improves obesity, glucose homeostasis and obesity-associated chronic inflammation in vivo. These findings indicate that increased PAR2 expression may be a valuable new biomarker for metabolic dysfunction and further, that PAR2 antagonism can be an effective intervention for treating metabolic dysfunction and obesity.
“We know that that eating too much and not exercising enough makes you overweight, and then obese, but why? The bottom line of this report is that obesity is an inflammatory disease, and inflammation plays a greater role in the downward spiral to obesity than most people realize.” said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. “It appears that once we can control the inflammation, we can begin to get everything else in line. Fortunately, these scientists have already identified one promising compound that seems to work.”
The Latest on: Obesity is an inflammatory disease
- Similar to Adults, Obesity Raises Kids' Odds for Severe COVID-19on June 3, 2020 at 9:55 am
The report was based on 50 cases of pediatric COVID-19 severe enough to require admission to a New York City hospital. Eleven (22%) of the 50 kids were obese, and six of the nine children who required ...
- Obesity and coronavirus: how can a higher BMI increase your risk?on June 3, 2020 at 4:48 am
Experts call for more weight loss treatment in UK as studies show obese people are more vulnerable ...
- How a fat cell's immune response makes obesity worseon June 3, 2020 at 12:22 am
When obesity occurs, a person's own fat cells can set off a complex inflammatory chain reaction that can further disrupt metabolism and weaken immune response—potentially placing people at higher risk ...
- Study explains how a fat cell's immune response makes obesity worseon June 2, 2020 at 10:32 pm
The study was led by scientists at Cincinnati Children's and the University of Cincinnati College of Medicine and was published in Nature Communications. The team reports that type I interferons, a ...
- Study reveals how a fat cell's immune response worsens obesityon June 2, 2020 at 5:03 pm
When obesity occurs, a person's own fat cells can set off a complex inflammatory chain reaction that can further disrupt metabolism and weaken immune response--potentially placing people at higher ...
- Drug for alcohol use disorder could also treat obesityon May 29, 2020 at 7:42 am
Treating obese mice with disulfiram, a drug for alcohol use disorder, led to significant weight loss and improved metabolic health, a new study reports.
- Researchers Discover Disabling Protein-coding Gene Could Prevent Obesity In Miceon May 26, 2020 at 4:27 am
Scientists discovered a new and effective way to prevent obesity in mice They inhibited a gene, which is found in the myeloid cells The group of mice with inhibited genes did not grow obese even when ...
- Obesity in mice prevented by disabling geneon May 24, 2020 at 5:18 am
Newly published research in mice finds that disabling a gene in the myeloid cells of the rodents prevents them from developing obesity.
- As obesity's link to COVID-19 grows, one family that lost 24-year-old daughter diets togetheron May 23, 2020 at 9:46 am
The extra weight on people in the 40-plus BMI range who contract COVID-19 increases the chance they will require hospitalization, likely in the ICU.
- Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infectionon May 22, 2020 at 6:19 am
Recent reports showed that individuals with obesity may be more vulnerable to severe complications of COVID-19 by virtue of the increased risk of chronic diseases driven by obesity . The reasons ...
via Bing News
The Latest on: Inflammatory disease
- Rare Kawasaki-like inflammatory disease that has struck 100 children in Britain 'is TWICE as common in youngsters of African heritage'on June 3, 2020 at 12:22 pm
A small study of 21 children admitted to a hospital in Paris with the condition found more than half (57 per cent) of youngsters had African heritage.
- Dell Children's treats one case of multisystem inflammatory syndrome linked to COVID-19, suspects moreon June 3, 2020 at 9:46 am
The rare – and sometimes deadly – mystery illness linked to the coronavirus has affected hundreds of children across the country.
- Study takes next step toward treatment for Alzheimer's diseaseon June 3, 2020 at 6:06 am
To date, scientists have identified 32 genetic mutations associated with an increased risk of Alzheimer's disease, with BYU contributing to many of those discoveries. Finding those links is important ...
- Complexa Completes Patient Enrollment in Phase 2 FIRSTx Trial Evaluating CXA-10 in Focal Segmental Glomerulosclerosis, a Rare and Severe Form of Kidney Diseaseon June 3, 2020 at 5:00 am
Complexa Inc. today announced the completion of patient enrollment in the FIRSTx study, a Phase 2 clinical trial evaluating the safety and efficacy of ...
- Black Children More Likely To Suffer Kawasaki-Like Coronavirus Inflammatory Conditionon June 3, 2020 at 3:24 am
A new study from Paris found that black children appear disproportionately more likely to develop the rare inflammatory symptoms linked to COVID-19 than other children.
- Coronavirus updates: Inflammatory disease found in 32 N.J. kids; Protesters urged to get tested. What you need to know.on June 2, 2020 at 4:49 pm
The second stage of New Jersey's plan to reopen from coronavirus closures begins June 15 with outdoor dining and nonessential retail businesses. Here's the latest information for Tuesday. (06/02/2020) ...
- Inflammatory Bowel Disease, Celiac Are Linked: Reviewon June 1, 2020 at 12:03 pm
They found that people with a previous diagnosis of celiac disease had a ninefold increased risk of IBD, and IBD patients had an increased risk of celiac disease, but to a smaller extent. "Clinicians ...
- New effective treatment for inflammatory diseases foundon June 1, 2020 at 7:27 am
New research conducted by the University of Liverpool and AKL Research and Development Ltd (AKLRD), published in Inflammopharmacology, highlights the potential benefits of a new drug treatment on the ...
- Inflammatory Bowel Disease Treatment Market is Estimated to Reach US Dollor 21.3 Bn by 2027on June 1, 2020 at 4:19 am
The global Inflammatory Bowel Disease Treatment Market size is expected to reach USD 21.3 billion by 2027, at a significant growth rate of 4.1% during the forecasted period 2020 to 2027. The research ...
- Remestemcel-L Improves Respiratory and Functional Outcomes in Patients With Inflammatory Lung Diseaseon June 1, 2020 at 3:00 am
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that treatment with its lead mesenchymal stem cell (MSC) product ...
via Bing News